Next Day Disclosure Return

Next Day Disclosure Return

Next Day Disclosure Return

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2026

Next Day Disclosure Return

Boan Biotech Announces 2026 Interim Results

Innovating & transforming full steam aheadGlobal Commercialization Poised for GrowthYantai, China, August 27, 2026 — Boan Biotech (6955.HK) today announced its interim results for the first half ...

DISCLOSEABLE TRANSACTION FINANCE LEASE AGREEMENT

ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026

IND Application for Boan Biotech’s TL1A/IL-23 Bispecific Antibody BA2201 Accepted in China

Boan Biotech today announced that the Investigational New Drug (IND) application for BA2201 has been accepted by the Center for Drug Evaluation (CDE) of China's National Medical Products Administr...

VOLUNTARY ANNOUNCEMENT CDE ACCEPTANCE OF IND APPLICATION FOR TL1A/IL-23 BISPECIFIC ANTIBODY BA2201